165 related articles for article (PubMed ID: 25596098)
1. Children with Down syndrome are high-risk for severe respiratory syncytial virus disease.
Stagliano DR; Nylund CM; Eide MB; Eberly MD
J Pediatr; 2015 Mar; 166(3):703-9.e2. PubMed ID: 25596098
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease.
Kristensen K; Stensballe LG; Bjerre J; Roth D; Fisker N; Kongstad T; Svendsen AL; Nielsen BW
Arch Dis Child; 2009 Oct; 94(10):785-9. PubMed ID: 19541682
[TBL] [Abstract][Full Text] [Related]
3. Healthy Late-preterm infants born 33-36+6 weeks gestational age have higher risk for respiratory syncytial virus hospitalization.
Helfrich AM; Nylund CM; Eberly MD; Eide MB; Stagliano DR
Early Hum Dev; 2015 Sep; 91(9):541-6. PubMed ID: 26186560
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study.
Yi H; Lanctôt KL; Bont L; Bloemers BL; Weijerman M; Broers C; Li A; Kiss A; Mitchell I; Paes B;
Pediatrics; 2014 Jun; 133(6):1031-7. PubMed ID: 24799541
[TBL] [Abstract][Full Text] [Related]
5. Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study.
Zachariah P; Ruttenber M; Simões EA
J Pediatr; 2012 May; 160(5):827-31.e1. PubMed ID: 22177993
[TBL] [Abstract][Full Text] [Related]
6. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
7. Hospitalization for Respiratory Syncytial Virus in Children with Down Syndrome Less than 2 Years of Age: A Systematic Review and Meta-Analysis.
Mitra S; El Azrak M; McCord H; Paes BA
J Pediatr; 2018 Dec; 203():92-100.e3. PubMed ID: 30266507
[TBL] [Abstract][Full Text] [Related]
8. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
[TBL] [Abstract][Full Text] [Related]
9. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study.
Kristensen K; Hjuler T; Ravn H; Simões EA; Stensballe LG
Clin Infect Dis; 2012 Mar; 54(6):810-7. PubMed ID: 22247121
[TBL] [Abstract][Full Text] [Related]
10. Respiratory Syncytial Virus-related Death in Children With Down Syndrome: The RSV GOLD Study.
Löwensteyn YN; Phijffer EWEM; Simons JVL; Scheltema NM; Mazur NI; Nair H; Bont LJ;
Pediatr Infect Dis J; 2020 Aug; 39(8):665-670. PubMed ID: 32332221
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007.
Chi H; Chang IS; Tsai FY; Huang LM; Shao PL; Chiu NC; Chang LY; Huang FY
J Formos Med Assoc; 2011 Jun; 110(6):388-96. PubMed ID: 21741007
[TBL] [Abstract][Full Text] [Related]
12. High incidence of recurrent wheeze in children with down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection.
Bloemers BL; van Furth AM; Weijerman ME; Gemke RJ; Broers CJ; Kimpen JL; Bont L
Pediatr Infect Dis J; 2010 Jan; 29(1):39-42. PubMed ID: 19907362
[TBL] [Abstract][Full Text] [Related]
13. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins.
Dotan M; Ashkenazi-Hoffnung L; Samra Z; Livni G; Yarden-Bilavsky H; Amir J; Bilavsky E
Isr Med Assoc J; 2013 Nov; 15(11):701-4. PubMed ID: 24511652
[TBL] [Abstract][Full Text] [Related]
14. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
Romero JR
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
[TBL] [Abstract][Full Text] [Related]
15. The impact of severe respiratory syncytial virus on the child, caregiver, and family during hospitalization and recovery.
Leidy NK; Margolis MK; Marcin JP; Flynn JA; Frankel LR; Johnson S; Langkamp D; Simoes EA
Pediatrics; 2005 Jun; 115(6):1536-46. PubMed ID: 15930214
[TBL] [Abstract][Full Text] [Related]
16. Down's syndrome is a risk factor for severe lower respiratory tract infection due to respiratory syncytial virus.
Galleguillos C; Galleguillos B; Larios G; Menchaca G; Bont L; Castro-Rodriguez JA
Acta Paediatr; 2016 Nov; 105(11):e531-e535. PubMed ID: 27537430
[TBL] [Abstract][Full Text] [Related]
17. Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma.
Jalink MB; Langley JM; Dodds L; Andreou P
Pediatr Infect Dis J; 2019 Nov; 38(11):1121-1125. PubMed ID: 31425330
[TBL] [Abstract][Full Text] [Related]
18. National cohort study showed that infants with Down's syndrome faced a high risk of hospitalisation for the respiratory syncytial virus.
Grut V; Söderström L; Naumburg E
Acta Paediatr; 2017 Sep; 106(9):1519-1524. PubMed ID: 28556255
[TBL] [Abstract][Full Text] [Related]
19. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
[TBL] [Abstract][Full Text] [Related]
20. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.
;
Pediatrics; 2014 Aug; 134(2):e620-38. PubMed ID: 25070304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
